The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...
FemPulse™, a bioelectronic medical technology company with first application overactive bladder, announced today that an ...
FemPulseTM, a bioelectronic medical technology company with first application overactive bladder, announced today that ...
Fakeeh Health | CEO – Fakeeh University Hospital, stated: “This strategic partnership with Verita Neuro reflects our ...
One argument for acupuncture in food animals is practicality. It requires no DEA license, carries no residue concerns and ...
Urology departments in England and Wales have reported seeing an increase in the number of 16- to 24-year-olds being admitted ...
Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...
Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an ...
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback